Neuroinflammation and Neuroprotection: An Update on (Future) Neurotrophin-Related Strategies in Multiple Sclerosis Treatment

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|18|12|1775-1784

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.12, 2011-04, pp. : 1775-1784

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neurotrophin Strategies for Neuroprotection: Are They Sufficient?

By Steiner Joseph   Nath Avindra  

Journal of Neuroimmune Pharmacology, Vol. 9, Iss. 2, 2014-03 ,pp. : 182-194

Springer Publishing Company

Access to resources Recommend Favorite

Neurodegeneration and Neuroprotection in Multiple Sclerosis

By  

Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-10 ,pp. : 4471-4474

Bentham Science Publishers

Access to resources Recommend Favorite

Immune Therapy of Multiple Sclerosis - Future Strategies

By  

Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-10 ,pp. : 4489-4497

Bentham Science Publishers

Access to resources Recommend Favorite

Multiple Sclerosis: Current and Future Treatment Options

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 7, Iss. 4, 2007-12 ,pp. : 292-299

Bentham Science Publishers

Access to resources Recommend Favorite

Cholinergic System and Neuroinflammation: Implication in Multiple Sclerosis

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 17, Iss. 2, 2017-07 ,pp. : 109-115

Bentham Science Publishers

Access to resources Recommend Favorite